Registration is open for Virtual Grand Rounds: COVID-19 Treatments on Wednesday, June 10, 6 - 7:30 p.m. Physicians can earn up to 1.5 AMA PRA Category 1 Credits™. This presentation is valid for 1 COPIC point.
With so much information swirling around treatments for COVID-19, our expert panelists will present what you need to know (and what your patients have been asking) about convalescent plasma, remdesivir and other therapies, as well as the latest epidemiology of COVID in Colorado. There will be time for questions from participants.
- Pampee Young, MD, PhD, Chief Medical Officer of Biomedical Services for the American Red Cross
- Stephen V. Cantrill, MD, Emergency Physician, Denver Health
- Rachel Herlihy, MD, MPH, State Epidemiologist
- John Hammer, MD, Carepoint Infectious Disease Specialist
ACCME Accreditation Statement
The Colorado Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Colorado Medical Society designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Relevant Financial Relationships:
The planners, faculty, and all others in control of the content of this CME activity have reported no financial relationships with commercial interests that would create a conflict of interest for CME purposes with the exception listed below.
John Hammer, MD; Gilead Pharmaceuticals; Principle Investigator: Gilead Remdesivir Trials 5773/5774
This presentation is valid for 1 COPIC point.